ArticleRespirology case reports2026
A Rare Association of Interstitial Lung Disease in Ankylosing Spondylitis: A Case Report and Review of Early Detection and Multidisciplinary Management.
Article in Respirology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Rare Association of Interstitial Lung Disease in Ankylosing Spondylitis: A Case Report and Review of Early Detection and Multidisciplinary Management.Respirology case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ankylosing spondylitis (AS) is a chronic inflammatory disorder of the axial skeleton, occasionally complicated by uncommon but increasingly recognized pulmonary involvement such as interstitial lung disease (ILD). We report a 35-year-old woman with a year-long history of inflammatory back pain and peripheral arthritis who fulfilled clinical and radiologic criteria for AS. Despite partial response to cDMARDs, she developed a productive cough. High-resolution CT revealed right upper-lobe ground-glass opacities consistent with early cellular ILD, supported by spirometry showing a moderate restrictive defect and negative autoimmune serology excluding overlapping connective tissue diseases. Conservative pulmonary monitoring and escalation to secukinumab resulted in marked improvement in both musculoskeletal and respiratory symptoms. This case highlights clinically under-recognized pulmonary involvement in AS, including early inflammatory (cellular) ILD, emphasizing diagnostic challenges and the importance of timely imaging and multidisciplinary management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.